IBX Secures Additional Capital — Shareholders Exercise Options

Imagion Biosystems announced on 10 May 2021 that it has received a total of $44,545.32 for the exercise of options.

The total was composed of 23,223.90 for 464,478 Listed Options exercisable at 5 cents, expiring of 26 November 2021 and 21,321,42 for the exercise of 710,714 Listed
Options exercisable at 3 cents, expiring at 28 April 2023.

Please click to review the full announcement at ASX.